These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 11900414)
21. Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance. Barone KS; Jain SL; Michael JG Cell Immunol; 1995 Jun; 163(1):19-29. PubMed ID: 7758127 [TBL] [Abstract][Full Text] [Related]
22. In vivo mechanisms of acquired thymic tolerance. Chen W; Issazadeh S; Sayegh MH; Khoury SJ Cell Immunol; 1997 Aug; 179(2):165-73. PubMed ID: 9268500 [TBL] [Abstract][Full Text] [Related]
23. Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Förster I; Lieberam I Eur J Immunol; 1996 Dec; 26(12):3194-202. PubMed ID: 8977322 [TBL] [Abstract][Full Text] [Related]
24. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine. Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709 [TBL] [Abstract][Full Text] [Related]
25. The role of CTLA-4 in regulating Th2 differentiation. Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003 [TBL] [Abstract][Full Text] [Related]
26. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. Eggena MP; Walker LS; Nagabhushanam V; Barron L; Chodos A; Abbas AK J Exp Med; 2004 Jun; 199(12):1725-30. PubMed ID: 15210748 [TBL] [Abstract][Full Text] [Related]
27. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889 [TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Haneda K; Sano K; Tamura G; Shirota H; Ohkawara Y; Sato T; Habu S; Shirato K Am J Respir Cell Mol Biol; 1999 Aug; 21(2):268-74. PubMed ID: 10423411 [TBL] [Abstract][Full Text] [Related]
29. Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells. van den Berg H; Greuter M; Kraal G; den Haan JM Immunobiology; 2010; 215(2):163-71. PubMed ID: 19278748 [TBL] [Abstract][Full Text] [Related]
30. Two-dimensional polyacrylamide gel electrophoretic characterization of proteins from organs of C3H mice expressing the scurfy (sf) genetic mutation during early and late stages of disease progression. Selkirk JK; Hite MC; Godfrey V; Merrick BA; He C; Griesemer RA; Daluge DR; Mansfield BK Appl Theor Electrophor; 1992; 3(2):97-107. PubMed ID: 1477119 [TBL] [Abstract][Full Text] [Related]
31. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510 [TBL] [Abstract][Full Text] [Related]
32. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694 [TBL] [Abstract][Full Text] [Related]
33. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. Huang H; Dawicki W; Zhang X; Town J; Gordon JR J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943 [TBL] [Abstract][Full Text] [Related]
34. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. Walunas TL; Bluestone JA J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090 [TBL] [Abstract][Full Text] [Related]
35. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage. Franco L; Benedetti R; Ferek GA; Massouh E; Fló J Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441 [TBL] [Abstract][Full Text] [Related]
36. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance. Fear VS; Burchell JT; Lai SP; Wikstrom ME; Blank F; von Garnier C; Turner DJ; Sly PD; Holt PG; Strickland DS; Stumbles PA J Immunol; 2011 Nov; 187(9):4561-70. PubMed ID: 21930961 [TBL] [Abstract][Full Text] [Related]
38. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Khattri R; Cox T; Yasayko SA; Ramsdell F Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581 [TBL] [Abstract][Full Text] [Related]
39. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Melamed D; Friedman A Eur J Immunol; 1994 Sep; 24(9):1974-81. PubMed ID: 8088317 [TBL] [Abstract][Full Text] [Related]
40. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway. Degermann S; Pria E; Adorini L J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]